Abbott announced that the US Food and Drug Administration (FDA) has approved the Tecnis Symfony intraocular lenses for the treatment of cataracts. The first in a new category of intraocular lenses ...

Santa Ana-based Abbott Medical Optics, a unit of Abbott Laboratories in Chicago, scored a regulatory approval this month. Abbott Medical said the Food and Drug Administration approved its Tecnis ...

Abbott’s Tecnis Symfony Intraocular Lenses earned FDA approval for the treatment of cataracts. During cataract surgery, clinicians remove the eye’s natural lens and replace it with an artificial lens.

IRVINE, Calif., Sept. 28, 2022 /PRNewswire/ -- Johnson & Johnson Vision,** a global leader in eye health and part of Johnson & Johnson MedTech,*** today announced availability of our ...

Please provide your email address to receive an email when new articles are posted on . The new Tecnis Symfony OptiBlue extended depth of focus IOL from Johnson & Johnson Vision provides improved ...

The Symfony, made by Abbott Medical Optics and approved by the Food and Drug Administration in July, uses a different type of technology. Rather than splitting light into near and distant focal points ...

Abbott, a global healthcare company, has received CE Marking (Conformité Européenne) in Europe for the TECNIS Symfony Extended Range of Vision intraocular lens (IOL) for the treatment of cataract ...

The U.S. Food and Drug Administration (FDA) has approved Abbott’s Tecnis Symfony Intraocular Lenses (IOL) for treating cataracts. According to Abbott, the Tecnis Symfony lenses are currently the only ...

SAN FRANCISCO — Trifocal intraocular lenses offer better near vision, whereas extended depth of focus (EDOF) lenses might be more suitable for older patients, new research suggests. "There is no ...